We are live on
!
Find out more
NIM
NEOS Investment Management Portfolio holdings
AUM
$27.1B
1-Year Est. Return
57.21%
This Fund
S&P 500
This Quarter
Est. Return
-2.03%
1 Year Est. Return
+57.21%
3 Year Est. Return
+163.05%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$19.8B
AUM Growth
+$2.5B
(+14%)
Cap. Flow
+$3.5B
Cap. Flow
% of AUM
17.7%
Top 10 Holdings %
Top 10 Hldgs %
39.03%
Holding
664
New
14
Increased
467
Reduced
94
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$333M |
| 2 |
NVIDIA
NVDA
|
+$242M |
| 3 |
Vanguard Russell 2000 ETF
VTWO
|
+$218M |
| 4 |
Apple
AAPL
|
+$213M |
| 5 |
Microsoft
MSFT
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$62.6M |
| 2 |
Xtrackers USD High Yield Corporate Bond ETF
HYLB
|
+$62.3M |
| 3 |
State Street SPDR Portfolio High Yield Bond ETF
SPHY
|
+$60.9M |
| 4 |
Powell Industries
POWL
|
+$24.3M |
| 5 |
AstraZeneca
AZN
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.36% |
| 2 | Communication Services | 12.13% |
| 3 | Consumer Discretionary | 10.25% |
| 4 | Healthcare | 6.37% |
| 5 | Consumer Staples | 6.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Teva Pharmaceuticals
TEVA
$42.5B
| – | – |
-24,331
| Closed | -$759K |
|
652
Terex
TEX
$7.74B
| – | – |
-182,966
| Closed | -$9.77M |
|
653
Timken Company
TKR
$8.91B
| – | – |
-126,375
| Closed | -$10.6M |
|
654
TSMC
TSM
$2.19T
| – | – |
-6,058
| Closed | -$1.84M |
|
655
UroGen Pharma
URGN
$2.3B
| – | – |
-53,576
| Closed | -$1.25M |
|
656
US Foods
USFD
$24.3B
| – | – |
-14,728
| Closed | -$1.11M |
|
|
657
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.1B
| – | – |
-1,674,354
| Closed | -$62.6M |
|
658
Viking Therapeutics
VKTX
$3.94B
| – | – |
-14,047
| Closed | -$494K |
|
659
Xencor
XNCR
$1.64B
| – | – |
-61,362
| Closed | -$939K |
|
660
Zai Lab
ZLAB
$2.92B
| – | – |
-75,165
| Closed | -$1.33M |
|
661
Zymeworks
ZYME
$1.73B
| – | – |
-77,115
| Closed | -$2.03M |
|
662
ArriVent BioPharma
AVBP
$1.46B
| – | – |
-32,487
| Closed | -$654K |
|
|
DAY
663
DELISTED
Dayforce
DAY
| – | – |
-16,017
| Closed | -$1.11M |
|
|
ONC
664
BeOne Medicines Ltd
ONC
$40.6B
| – | – |
-8,187
| Closed | -$2.49M |
|
Similar funds
NA
FDCDDQ
TWC
WP
N
PCH
NEOS Investment Management's Q1 2026 Portfolio in Review
As of Q1 2026, NEOS Investment Management held 664 positions worth $19.8B, up 14% from $17.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
NEOS Investment Management deployed $3.5B of net new capital in Q1 2026, opening 14 new positions and adding to 467 existing holdings. Its largest new stake was Enbridge: 841,618 shares worth $45.5M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 39% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Caterpillar, an estimated $19M trimmed.
- NEOS Investment Management's largest Q1 2026 buy was Enbridge: 841,618 shares worth $45.5M.
- NEOS Investment Management added most to Walmart Inc in Q1 2026, an estimated $333M increase.
- NEOS Investment Management's biggest Q1 2026 reduction was Caterpillar, cutting an estimated $19M.
- NEOS Investment Management fully exited iShares Broad USD High Yield Corporate Bond ETF in Q1 2026, selling an estimated $62.6M.
- NEOS Investment Management's ten largest holdings make up 39% of its $19.8B portfolio in Q1 2026.
- NEOS Investment Management opened 14 new positions and closed 89 in Q1 2026.
- NEOS Investment Management's portfolio value rose 14% quarter-over-quarter to $19.8B.
Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.